Company: NCEL
Filing Date: 2025-06-09
Form Type: F-4/A
Source: 0001213900-25-052354
Chunk: 761

Company: NewcelX Ltd.
Filing Date: 2025-06-09
Form: F-4/A
Chunk 761
---
 a committed equity facility. Pursuant to the Facility SPA, the Company has the right from time to time at its option to sell to Alpha up to $ 25.0million of Company Common Shares, subject to certain conditions and limitations set forth in the Facility SPA. The purchase price of the Company Common Shares that the Company elects to sell to Alpha pursuant to the Facility SPA will be 95% of the volume weighted average price of the Company Common Shares during the applicable purchase date on which the Company has timely delivered written notice to Alpha directing it to purchase Company Common Shares under the Facility SPA. In connection with the execution of the Facility SPA, the Company agreed to issue a pre -fundedwarrant, or the Pre -FundedWarrant, to purchase $ 250,000in Company Common Shares to Alpha as consideration for its irrevocable commitment to purchase the Company Common Shares upon the terms and subject to the satisfaction of the conditions set forth in the Facility SPA. Annex F-28

Annex G Kadimastem Ltd. Financial Statements as of December 31, 2024 Table of Contents

|                                                                         |     | Annex G 
 Page    |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 1281) |     | G-2     |
| Statements of Financial Position                                        |     | G-3     |
| Statements of Profit or Loss and Other Comprehensive Loss               |     | G-4     |
| Statements of Changes in Equity                                         |     | G-5     |
| Statements of Cash Flows                                                |     | G-7     |
| Notes to the Financial Statements                                       |     | G-8     |

Annex G-1

| Kost Forer Gabbay & Kasierer |     | Tel.: +972-3-6232525 |
| 144A Derech Menachem Begin   |     | Fax: +972-3-5622555  |
| Tel Aviv 6492102             |     | ey.com               |

Report of Independent Registered Public Accounting Firm To the Shareholders and the Board of Directors of Kadimastem Ltd. Opinion on the Financial Statements We have audited the accompanying statements of financial position of Kadimastem Ltd. (the “Company”) as of December 31, 2024 and 2023, the related statements of profit or loss and other comprehensive loss, changes in equity and cash flows for each of the three years in the period ended December 31, 202